home / stock / fstx / fstx news

FSTX News and Press, F-star Therapeutics Inc Com From 09/16/21

Stock Information
Company Name: F-star Therapeutics Inc Com
Stock Symbol: FSTX
Market: NASDAQ
Menu
FSTX FSTX Quote FSTX Short FSTX News FSTX Articles FSTX Message Board
Get FSTX Alerts

News, Short Squeeze, Breakout and More Instantly...
FSTX - F-star Therapeutics to Present FS120 Phase 1 Trial-in-Progress Update at ESMO 2021

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Sept. 16, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX) , a clinical-stage biopharmaceutical company dedicated to developing next generation bispecific immunotherapies to transform the lives of patients with cancer,...
FSTX - F-star Therapeutics to Present at H.C. Wainwright 23rd Annual Global Investment Conference

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX) , a clinical-stage biopharmaceutical company dedicated to developing next generation bispecific immunotherapies to transform the lives of patients with cancer,...

FSTX - F-star Therapeutics, Inc. (FSTX) CEO Eliot Forster on Q2 2021 Results - Earnings Call Transcript

F-star Therapeutics, Inc. (FSTX) Q2 2021 Earnings Conference Call August 12, 2021, 09:00 AM ET Company Participants Lindsey Trickett - VP of IR Eliot Forster - CEO Darlene Deptula-Hicks - CFO Conference Call Participants Daina Graybosch - SVB Leerink Matt Phipps - William Blair Hartaj Singh -...

FSTX - F-star Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Aug. 12, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX) , a clinical-stage biopharmaceutical company dedicated to developing next generation bispecific immunotherapies to transform the lives of patients with canc...
FSTX - F-star Therapeutics is Granted Composition of Matter Patent for its Novel Second Generation STING Agonist, SB 11285

Patent protection in U.S. runs through 2037 CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX) (“F-star” or the “Company”) , a clinical-stage biopharmaceutical company ded...

FSTX - F-star Therapeutics Announces Collaboration with MSD to Evaluate FS120 in Combination with KEYTRUDA

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX) , a clinical-stage biopharmaceutical company dedicated to developing next generation bispecific immunotherapies to transform the lives of patients with cancer, ...

FSTX - F-star Therapeutics to Announce Second Quarter Results and Host Conference Call on August 12, 2021

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Aug. 02, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next generation immunotherapies to transform the lives of patients with cancer, announced today ...
FSTX - F-star Therapeutics Provides Interim Update on SB 11285 First-In-Human Dose-Escalation Study in Patients with Advanced Solid Tumors

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., July 26, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX) (“F-star” or the “Company”) , a clinical-stage biopharmaceutical company dedicated to developing next generation immunotherapies...

FSTX - Aerpio Pharmaceuticals, GBS leads healthcare gainers; Virpax Pharmaceuticals, Nephros among major losers

Gainers: Aerpio Pharmaceuticals (ARPO) +54%, GBS (GBS) +25%, 9 Meters Biopharma (NMTR) +19%, Alterity Therapeutics (ATHE) +10%, F-star Therapeutics (FSTX) +9%.Losers: Virpax Pharmaceuticals (VRPX) -13%, Nephros (NEPH) -12%, ...

FSTX - F-star Therapeutics rises on agreement with AstraZeneca for STING inhibitors

metamorworks/iStock via Getty Images F-star Therapeutics (FSTX) has added ~14.3% in the pre-market after announcing a licensing agreement with AstraZeneca (AZN) for next-generation Stimulator of Interferon Genes ((STING)) inhibitor compounds. Per the terms, Anglo-Swedish d...
Previous 10 Next 10